Literature DB >> 30742236

[Retroperitoneal hemangiopericytoma-a rare case with multiple relapses-even 20 years after primary diagnosis].

Markus Maier1, Rainer Hofmann2, Fiona Rodepeter3, Axel Hegele2.   

Abstract

A 41-year-old man without previous illness presented at our clinic with progressive pain in the lower abdomen and intermittent pain in the left flank. We found a lesion of unknown dignity which had anatomical contact to the bladder and rectum. Histological examination confirmed the diagnosis of hemangiopericytoma. It is grouped under the general term solitary fibrous tumor (SFT). The potential for malignancy varies. To calculate the tendency of metastases or recurrence and overall survival, it is necessary to use a risk stratification model to individualize treatment. Our rare case with an appearance of a relapse 14 and 20 years after the primary resection and progressive proliferation rate underlines the importance of individualized management and long-term and close follow-up of this tumor entity.

Entities:  

Keywords:  Follow-up of rare solid tumors; Hemangiopericytoma; Retroperitoneal relapse; Risk management of hemangiopericytoma; Solitary fibrous tumor

Mesh:

Year:  2019        PMID: 30742236     DOI: 10.1007/s00120-019-0879-4

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  9 in total

1.  Prognosis of solitary fibrous tumors: a multicenter study.

Authors:  Winan J van Houdt; Charlotte M A Westerveld; Joyce E P Vrijenhoek; Joost van Gorp; Frits van Coevorden; Cornelis Verhoef; Thijs van Dalen
Journal:  Ann Surg Oncol       Date:  2013-09-20       Impact factor: 5.344

2.  Multiple recurrent malignant solitary fibrous tumors: long-term follow-up of 24 years.

Authors:  Chang Kwon Park; Deok Heon Lee; Ji Young Park; Sun Hwa Park; Kun Young Kwon
Journal:  Ann Thorac Surg       Date:  2011-04       Impact factor: 4.330

3.  Size and Location are the Most Important Risk Factors for Malignant Behavior in Resected Solitary Fibrous Tumors.

Authors:  Sepideh Gholami; Michael R Cassidy; Amanda Kirane; Deborah Kuk; Bhumika Zanchelli; Christina R Antonescu; Samuel Singer; Murray Brennan
Journal:  Ann Surg Oncol       Date:  2017-10-16       Impact factor: 5.344

Review 4.  Solitary fibrous tumor of the pleura.

Authors:  Lary A Robinson
Journal:  Cancer Control       Date:  2006-10       Impact factor: 3.302

5.  [Solitary fibrous tumor and haemangiopericytoma: what is new?].

Authors:  T Knösel; B Schulz; K Katenkamp; D Katenkamp; I Petersen
Journal:  Pathologe       Date:  2010-03       Impact factor: 1.011

6.  Solitary fibrous tumors of the pleura.

Authors:  Marc de Perrot; Stefan Fischer; Marie-Anne Bründler; Yasuo Sekine; Shaf Keshavjee
Journal:  Ann Thorac Surg       Date:  2002-07       Impact factor: 4.330

7.  Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model.

Authors:  Elizabeth G Demicco; Min S Park; Dejka M Araujo; Patricia S Fox; Roland L Bassett; Raphael E Pollock; Alexander J Lazar; Wei-Lien Wang
Journal:  Mod Pathol       Date:  2012-05-11       Impact factor: 7.842

8.  Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) database.

Authors:  S Salas; N Resseguier; J Y Blay; A Le Cesne; A Italiano; C Chevreau; P Rosset; N Isambert; P Soulie; D Cupissol; C Delcambre; J O Bay; P Dubray-Longeras; M Krengli; B De Bari; S Villa; J H A M Kaanders; S Torrente; D Pasquier; J O Thariat; L Myroslav; C V Sole; H F Dincbas; J Y Habboush; T Zilli; T Dragan; K Khan R; G Ugurluer; T Cena; F Duffaud; N Penel; F Bertucci; D Ranchere-Vince; P Terrier; S Bonvalot; N Macagno; C Lemoine; M Lae; J M Coindre; C Bouvier
Journal:  Ann Oncol       Date:  2017-08-01       Impact factor: 32.976

9.  Local recurrence and distant metastases 18 years after resection of the greater omentum hemangiopericytoma.

Authors:  Maciej Slupski; Ilona Piotrowiak; Zbigniew Wlodarczyk
Journal:  World J Surg Oncol       Date:  2007-06-06       Impact factor: 2.754

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.